[Homozygous Sickle Cell Children Treated with Hydroxyurea in Brazzaville (Congo)]. 2019

J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
Faculté des sciences de la santé, université Marien-Ngouabi, Brazzaville, Congo.

The objective of this study is to reduce the morbidity of children with homozygous sickle cell disease presenting severe forms. We have conducted a longitudinal study between November 2015 and September 2017 at the Brazzaville University Hospital. Children with sickle cell disease requiring treatment with hydroxyurea were included. The variables studied were therapeutic compliance, evolutive profile of nutritional status, indications of hydroxyurea, electrophoresis of hemoglobin, blood count, and toxicity. The statistical test used was Student test with a significance threshold of less than 0.05. One thousand twenty-four children were monitored for sickle cell disease, 107 of which had received hydroxyurea (10.4%). The indications for hydroxyurea were recurrent anemic attacks (≥ 4) in 62 cases (57.9%), neurological crises 19 cases (17.8%), recurrent hyperalgesic crises in 17 cases (15.9%), priapism in 4 cases (3.7), and acute thoracic syndrome in 2 cases (1.9%). Therapeutic compliance was good in 89.5% of them. A rapid and lasting clinical improvement was noted in the majority of patients with hyperalgesic attacks (88.2%) and anemic attacks (88.7%), two recurrences for the cerebrovascular accidents, and an absence of recurrence of priapism and of the acute thoracic syndrome. From the biological point of view, there was a significant increase in fetal hemoglobin (1.2 to 16.2%; P  < 0.05), hemoglobin (7 to 8.3 g/dl; P < 0.05), mean cell volume (80.8 to 96 fl; P  < 0.05) and a significant decrease in mean white blood cell count (15,633 to 9,872/mm3; P  < 0.05) and platelets (387,002 to 324,400/mm3; P  < 0.05). The signs of toxicity observed were mainly vomiting and thrombocytopenia in two cases each, one case with headache and the other with neutropenia. Indications for use of hydroxyurea therapy in children with sickle cell disease in Brazzaville are common. These are dominated by recurrent anemic seizures, strokes, and hyperalgesic seizures. The excellent evolution of these complications under hydroxyurea represents an interesting alternative in our countries with limited resources.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D011317 Priapism A prolonged painful erection that may lasts hours and is not associated with sexual activity. It is seen in patients with SICKLE CELL ANEMIA, advanced malignancy, spinal trauma; and certain drug treatments. Priapisms
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003223 Congo A republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO and south of Cameroon. Its capital is Brazzaville. Republic of the Congo,Congo (Brazzaville)
D005260 Female Females
D005319 Fetal Hemoglobin The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated (usually above 0.5%) in children and adults affected by LEUKEMIA and several types of ANEMIA. Hemoglobin F,Hemoglobin, Fetal

Related Publications

J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
January 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
September 2013, The Nigerian postgraduate medical journal,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
January 2024, American journal of hematology,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
January 2000, Bulletin de la Societe belge d'ophtalmologie,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
January 1999, Acta haematologica,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
January 2023, Anemia,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
January 2000, Human heredity,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
April 2008, Pediatric clinics of North America,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
February 2010, Hematology/oncology clinics of North America,
J R Mabiala-Babela, and E R Nika, and L C Ollandzobo Ikobo, and A N Ofamalekou Gnakingue, and B P S Ngoulou, and S V Missambou Mandilou
October 2003, British journal of haematology,
Copied contents to your clipboard!